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Myosin light-chain phosphatase is a trimeric protein that hydrolyses phosphorylated myosin
II light chains (MYLII) to cause relaxation in smooth muscle cells including those of the
uterus. A major component of the phosphatase is the myosin targeting subunit (MYPT),
which directs a catalytic subunit to dephosphorylate MYLII. There are 5 main MYPT family
members (MYPT1 (PPP1R12A), MYPT2 (PPP1R12B), MYPT3 (PPP1R16A), myosin bind-
ing subunit 85 MBS85 (PPP1R12C) and TIMAP (TGF-beta-inhibited membrane-associ-
ated protein (PPP1R16B)). Nitric oxide (NO)-mediated smooth muscle relaxation has in
part been attributed to activation of the phosphatase by PKG binding to a leucine zipper
(LZ) dimerization domain located at the carboxyl-terminus of PPP1R12A. In animal studies,
alternative splicing of PPP1R12A can lead to the inclusion of a 31-nucleotide exonic seg-
ment that generates a LZ negative (LZ-) isovariant rendering the phosphatase less sensi-
tive to NO vasodilators and alterations in PPP1R12ALZ- and LZ+ expression have been
linked to phenotypic changes in smooth muscle function. Moreover, PPP1R12B and
PPP1R12C, but not PPP1R16A or PPP1R16B, have the potential for LZ+/LZ- alternative
splicing. Yet, by comparison to animal studies, the information on human MYPT genomic
sequences/mRNA expressions is scant. As uterine smooth muscle undergoes substantial
remodeling during pregnancy we were interested in establishing the patterns of expression
of human MYPT isovariants during this process and also following labor onset as this could
have important implications for determining successful pregnancy outcome.
Objectives
We used cross-species genome alignment, to infer putative human sequences not avail-
able in the public domain, and isovariant-specific quantitative PCR, to analyse the expres-
sion of mRNA encoding putative LZ+ and LZ- forms of PPP1R12A, PPP1R12B and
PPP1R12C as well as canonical PPP1R16A and PPP1R16B genes in human uterine
smooth muscle from non-pregnant, pregnant and in-labor donors.
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Results
We found a reduction in the expression of PPP1R12A, PPP1R12BLZ+, PPP1R16A and
PPP1R16B mRNA in late pregnancy (not-in-labor) relative to non-pregnancy.
PPP1R12ALZ+ and PPP1R12ALZ- mRNA levels were similar in the non-pregnant and
pregnant not in labor groups. There was a further reduction in the uterine expression of
PPP1R12ALZ+, PPP1R12CLZ+ and PPP1R12ALZ- mRNA with labor relative to the preg-
nant not-in-labor group. PPP1R12A, PPP1R12BLZ+, PPP1R16A and PPP1R16B mRNA
levels were invariant between the not in labor and in-labor groups.
Conclusions
MYPT proteins are crucial determinants of smooth muscle function. Therefore, these alter-
ations in human uterine smooth muscle MYPT isovariant expression during pregnancy and
labor may be part of the important molecular physiological transition between uterine quies-
cence and activation.
Introduction
The human uterus during pregnancy undergoes a dramatic increase in size whilst maintaining a
state of relative quiescence to accommodate the growing fetus and placenta. These morphological
and physiological changes culminate at the end of pregnancy in a switch to a coordinated active
contractile state to facilitate delivery of the fetus and placenta. The mechanisms that regulate the
effective transitioning from the pro-gestational quiescent phase into the contractile phenotype
required for labor remain poorly understood but are likely to include alterations in myofilament
contractile phenotype evinced by differences in sensitivity to physiological stimuli.
Contraction of uterine smoothmuscle is regulated by action potential- and G-protein-cou-
pled receptor (GPCR) agonist-generated increases in intracellular calcium leading to Ca2+- cal-
modulin- dependentmyosin light chain kinase (MYLK) activation and phosphorylation of the
regulatory light chains of myosin (MYLII). This facilitates acto-myosin crossbridge formation
and force enhancement. Myosin phosphatase (MYLP) is a trimeric protein that reversesMYL
II phosphorylation to cause smooth muscle relaxation. MYLP is made up of a 38 kDa catalytic
type 1 protein phosphatase (PP1c) subunit which dephosphorylatesMYII, a 110 kDa targeting
subunit—calledmyosin phosphatase targeting subunit (MYPT)—which controls the activity of
the PPP1c subunit and a small 20 kDa regulatory (M20) subunit [1]. In addition to the Ca2+-
dependent activation of MYLK and force enhancement, the GPCR pathway inhibits myosin
phosphatase activity leading to additional force enhancement at any given [Ca2+][2]. Nitric
oxide (NO) donors activate MYLP to enhance smoothmuscle relaxatory capacity. It has been
suggested that, in part, this arises from protein kinase G (PKG) binding to a leucine zipper
(LZ) region of the MYPT subunit resulting in enhanced activity of MYLP protein, myosin
dephosphorylation and smoothmuscle relaxation[3,4] [5].
There are five main mammalian MYPT related proteins each the product of separate genes:
MYPT1 (also known as PPP12R1A (http://www.genenames.org/), MYPT2 (PPP1R12B),
MYPT3 (PPP1R16A), MBS85 (PPP1R12C) and TIMAP (PPP1R16B). PPP1R12A, PPP1R12B
and PPP1R12C are MYPT isoforms that have up to 80% amino acid sequence homology in the
leucine zipper (LZ) dimerization region [X]L[XX]L[XX]DNQRLKDEN[X]ALIRVISKLSK (Fig
1). PPP1R16B and PPP1R16A are distantly related isoforms capable of auto-activation of
PPP1c phosphatase function [6]. The significanceof the LZ region (LZ+) of PPP1R12A, and
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possibly PPP1R12C and PPP1R12B, appears to reside in it conferring sensitivity to PKG binding
and activation of the phosphatase [4,5]. However, alternative splicing of PPP1R12A results in the
inclusion of a 31-nucleotide exonic segment that shifts the open reading frame to generate a
shorter PPP1R12A isovariant that is LZ negative (LZ-) [7].The LZ- isovariant has been suggested
to be less sensitive to NO donors or PKG binding[8]. Thus, the LZ- and LZ+ isovariants of
PPP1R12Amay influence different phosphatase activities. Further, their relative expressions are
regulated in tissue and biological context-specificmanners [9]. For example, large arteries with a
slow contractile phenotype, like the aorta and pulmonary artery, show higher levels of the LZ+
isovariant and increased responsiveness to nitric oxide/PKG-mediated stimuli [10]. In contrast,
smoothmuscle tissues that have a fast contractile phenotype, such as the portal vein may express
higher levels of the LZ- isovariant rendering them relatively insensitive to PKG-mediated relaxa-
tion [10]. Alterations in smoothmuscle PPP1R12A LZ- to LZ+ expression have also been
reported to be associatedwith developmental or phenotypic differences [8,11].
In human smoothmuscle it is unknown if changes in PPP1R12ALZ+ and PPP1R12ALZ-
isovariants occur with altered physiological circumstances. Indeed, the human PPP1R12A
gene sequence [http://www.ncbi.nlm.nih.gov/nuccore/NM_002480.2] does not list a
PPP1R12ALZ- isovariant. Similarly, only sequences encoding for LZ+ forms of PPP1R12C and
PPP1R12B are listed. This leaves open the general question of if, and to what extent, LZ- iso-
variants of PPP1R12A, PPP1R12C and PPP1R12B are expressed in human smooth muscle.
Furthermore it is not known how the expressions of the 5 canonical MYPT gene products, and
the relative expressions of individualMYPT LZ+/LZ- isovariants in human uterine smooth
muscle, vary with pregnancy and labor. There is some recent evidence pointing to alterations
of PPP1R12A phosphorylation being associated with pregnancy [12] and with the uterine
smoothmuscle contraction-relaxation cycle [13] adding importance to the need to understand
Fig 1. Schematic representation of the exon map of mammalian PPP1R12A, PPP1R12B and PPP1R12C leucine zipper positive (LZ+) isovariants.
A-C. The NCBI accession numbers, nucleotide sequence identity and exon map of known MYPT LZ positive isovariants are shown. Nucleotide and amino
acid sequences depicting the 4-heptad leucine repeat within the carboxyl-terminal exons are also displayed above.
doi:10.1371/journal.pone.0164352.g001
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the breadth of expression of MYPT family members evident in these circumstances.We pro-
pose that the switch of human uterine smoothmuscle from pro-gestational relative quiescent
phenotype to a contractile phenotype may be associated with alterations in the expression of
MYPT isoforms. Therefore, this study encompasses two approaches. First, we have performed
cross-species bioinformatic analyses to infer the putative sequences of LZ- isovariants of
human PPP1R12A, PPP1R12C and PPP1R12B. Second, using quantitative PCR, we have
investigated the expression patterns of mRNA encoding known PPP1R12LZ+ and predicted
PPP1R12LZ- isovariants, as well as PPP1R16A and PPP1R16B, in uterine tissue from non-
pregnant women, term pregnant women not in labor and those in active labor.
Materials and Methods
Sample collection and tissue microdissection
All research involving human participants were approved by National Research Ethics Service
Committee North East—Newcastle & North Tyneside 1 Research Ethics Committee reference:
08/H0906/21+5 and conducted according to the principles expressed in the Declaration of Hel-
sinki. All donors gave written informed consent. Myometrial tissue was obtained from non-preg-
nant (NP) premenopausal women undergoing hysterectomy for benign gynaecologicaldisorders
(e.g. dysmenorrhea,menorrhagia) and from non-laboring pregnant women at term (37 to 42
weeks gestation) undergoing Cesarean deliverywith the following indications: maternal request,
breech presentation, previous Cesarean delivery or placenta previa. Samples were also obtained
fromwomen in active labor who had Cesarean deliveries for fetal distress, poor progress and
maternal request. Myometrial biopsies were obtained from the upper part of the lower uterine
segment hysterotomy for Cesarean section Patient’s details are outlined in Table 1. Myometrial
biopsies were immediately placed in ice-cold tissue collection buffer (TCB); modifiedKrebs solu-
tion -154mMNaCl / 5.4mMKCl / 1.2mMMgSO4.7H20 / 10mMMOPS / 5.5mM glucose /
1.6mMCaCl2.2H20; pH 7.4) and transported to the laboratory where they were immediately
micro-dissectedand cleaned of all adherent fat and extraneous tissue, using a stereomicroscope.
The micro-dissected segments were immediately frozen in liquid nitrogen and stored at -80°C
until subsequently RNA extraction and quantitative real time PCR analysis.
RNA and cDNA preparation
Micro-dissectedmyometrial tissues were homogenized and RNA extracted using a Qiagen
RNeasy fibrous kit as previously described in [14]. Briefly, 30mg of tissue was homogenized in
Table 1. Details of donors used in this study.
Characteristics NP NIL IL
Number of patients 14 15 12
Age 37.5±1.8 32±2.0 31.5±1.6
Body mass index 28±1.3 25.5±1.3 29±2.0
Smoker 36% 17% 0%
Parity 2.5±1.6 1±0.26 0.5±0.22
Gravidity 1±0.40 2.0±0.31 2.0±0.31
Gestation age (weeks) 41±0.40 39.0±0.34 41±0.63
Birth weight (g) 3365±147 3545±164
Birth weight centile 50±10.57 48±12.4
NP = non-pregnant; NIL = term not in labor; IL = in-labor.
doi:10.1371/journal.pone.0164352.t001
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lysis buffer using a mechanical homogenizer (Minilys, BertinTechnologies). The tissue was
homogenized for 5 cycles, each lasting 25 seconds and homogenate was kept on ice between
cycles. Extracted RNA samples were treated with DNase I to digest any contaminant DNA and
concentration and quality of the eluted samples were assessed by measuring optical density in a
NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). RNA sam-
ples (100 ng) with A260/280 values> 1.8 and A260/230 values between 1.8–2.2 were subject to
reverse transcription using AffinityScriptMultiple Temperature cDNA synthesis Kit 200436
(Stratagene).
Quantitative real-time PCR
Quantitative PCR (50 cycles) with PerfectProbe amplification (Primer Design, UK) was used
to measure mRNA expression of individual MYPT isovariants using pre-verified primer sets
(see below). The following protocol was used: enzyme activation hot start at 95°C for 10 min,
denaturing at 95°C for 15 s and extension at 60°C for 60 s. The sample triplicates were within
1 Ct of each other and were>10 Ct values different from no template or water-only controls.
No specific products were obtained in RT- and no template negative control reactions, indi-
cating that all reagents were free of contamination and PCR products in the template positive
reactions did not originate from genomic DNA contamination. 10 μl of sample cDNA, run in
triplicate, were used as a template for each 25 μl PCR. Standard concentration-curveswere
generated using human reference smooth muscle cDNA (product # 636547, Clontech,
France), which also served as an in-assay calibrator for fold-change in gene expression
assessment.
PCR cycling conditions for individual primer sets, prior to PerfectProbe annealing, were
optimized using SYBR Green amplicon detection in human smoothmuscle reference RNA,
human skeletal muscle RNA, cardiac smoothmuscle and uterine smoothmuscle RNA. SYBR
Green cycling parameters were as follows: initial heat step at 95°C for 3 minutes, denaturing at
95°C for 15 s, annealing at 60°C for 60 s, extension at 72°C for 60 seconds followed step and
hold dissociation curve step. Product amplicons from individual primer sets were cloned into a
‘gBlock gene fragments’ double stranded synthetic template and the resultant sequence verified
positive control amplicon template was resuspended to obtain a working dilution of 2×105/ μl.
The amplicon template complex was run along with all the samples of interest as an internal
positive control with a Ct of 18–20 indicating optimal cycling parameters for the primer in
question.
Agarose gel electrophoresis
The size of amplicon obtained from the reactions above was assessed using agarose gel electro-
phoresis. Briefly, 8 μl of PCR products was mixed with 2 μl of loading buffer (40% sucrose, 1
mM EDTA and 0.03% xylene cyanol) and separated by gel electrophoresis on a 2% agarose gel
stained with ethidium bromide. The products were visualized using ultraviolet light transillu-
minator and photographed using Kodak camera according to the manufacturer’s instructions.
Statistics
MYPT data sets were not to be normally distributed and therefore the data were log trans-
formed using the formula [Y = log (Y)] and analysed using GraphPad Prism 4.0 (Hearne Scien-
tific Software). Differences in the mean mRNA expression between non-pregnant and
pregnant groups were assessed using ANOVA with Tukey’s Post hoc analysis. Results are pre-
sented as mean ± SEM and statistical significancewas taken as p< 0.05.
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Results and Discussion
Bioinformatic inference of human PPP1R12A, PPP1R12B and
PPP1R12C LZ- sequences
Information on the LZ+ isovariants of human PPP1R12A [NM_002480.1], PPP1R12B
(NM_002481.3) and PPP1R12C (NM_017607.3) sequences are publicly available sequence
[http://www.ncbi.nlm.nih.gov/nuccore/NM_002481.3/NM_017607.3]. However, correspond-
ing sequence information on the human LZ- isovariants is, surprisingly, lacking.Mammalian
PPP1R12A LZ- sequences containing the 31-nucleotide exonic insert segment ‘GTGTCCG
GCAAGAGTCAGTATCTTCTGGGCG’ are available for chicken (NM_205123) and mouse
(NM_027892). Therefore, these were aligned to the human cDNA exonic sequences of
PPP1R12A, PPP1R12B and PPP1R12C to enable species cross-comparison of these sequences.
Figs 1–3 focus on the theoretical sequences of LZ+ and LZ- sequences in human MYPT thereby
enabling the identification of isovariant-specificQPCR primers for various MYPTLZ+ and
LZ- forms. Other investigators have presented similar multispecies bioinformatics analyses for
the PPP1R12A gene [15]. This enabled identification of the C-terminal region at which genera-
tion of putative human LZ- isovariants could occur via insertion of a 31-nucleotide exonic seg-
ment (immediately prior to the last exon of the LZ+ versions). The resultant predicted human
LZ- reads are displayed in Fig 3. The ‘spliced-in’ exon gene sequences, indicated as exon 23A of
PPP1R12ALZ-, exon 22A of PPP1R12BLZ- and exon 20A of PPP1R12CLZ-, shifted the open
Fig 2. Bioinformatic inference of putative human PPP1R12A, PPP1R12B and PPP1R12C LZ- isovariant
sequences. The publicly available sequence information for chicken and mouse PPP1R12ALZ- isovariants are shown
to display the 31 nucleotide exonic insert ‘GTGTCCGGCAAGAGTCAGTATCTACTGGGCG’. This generates a shift in
the reading frame and a LZ negative read is located at the start of the black lettered exon. Cross-alignment with the
human published PPP1R12A, PPP1R12B and PPP1R12C sequences enabled identification of the region to
theoretically insert the 31 nucleotides. Doing so resulted in the translated LZ negative protein sequence ‘V[X]
GKSQYLLGG’ of the chicken and mouse sequences also appearing in the predicted human LZ- sequences.
doi:10.1371/journal.pone.0164352.g002
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reading frames to generate sequences that translate to amino acid sequences devoid of a LZ
repeat (Fig 3).
Next, PCR primers were designed to either exclude (LZ+) or include the exonic segment
(LZ-) of PPP1R12A, PPP1R12B or PPP1R12C to enable expression analysis individual LZ+
and LZ- isovariants. The sequences of individual primers and positions of primer-directed
amplicons on the genes are displayed in Table 2 and S1 Table. Melt curve analyses of SYBR
green QPCR reactions illustrated the formation of a single amplicon for PPP1R12ALZ+,
PPP1R12ALZ-, PPP1R12BLZ+ and PPP1R12CLZ+, Fig 4. However, multiple primer sets for
the PPP1R12BLZ- and PPP1R12CLZ- sequences failed to amplify PCR products with specific-
ity (multiple peaks were observed in the melt curves) and/or insufficient divergence in amplifi-
cation from no-template controls. This was suggestive of very low, or absent, transcript
expression for PPP1R12BLZ- and PPP1R12CLZ- isovariants.
PCR reactions indicated amplification of mRNA encoding PPP1R16A and PPP1R16B in
the samples of interest. Therefore, primer sets for PPP1R12ALZ+, PPP1R12ALZ-,
PPP1R12BLZ+, PPP1R12CLZ+, PPP1R16A and PPP1R16B were annealed to Perfect Probes to
determinemRNA expression of each sequence in uterine smoothmuscle samples from non-
pregnant and pregnant not-in-labor (NIL) or in-labor (IL) women.
Down regulation of PPP1R12ALZ+ and PPP1R12ALZ-, mRNA
expression in labor
Isovariant-specific PerfectProbes detected amplification of mRNA encoding PPP1R12ALZ
+ and PPP1R12ALZ- in all the non-pregnant and pregnant myometrial samples analysed in
this study. PPP1R12ALZ+mean fold-change relative to calibrator values was 0.74±0.11 in NP,
Fig 3. Exon map of ‘predicted’ human PPP1R12A, PPP1R12B and PPP1R12C LZ negative (LZ-) isovariants. The inferred LZ- exon maps, predicted
amino acid and nucleotide sequences of the terminal exons of PPP1R12A, PPP1R12B and PPP1R12C (A-C) are displayed above.
doi:10.1371/journal.pone.0164352.g003
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0.46±0.05 in NIL and 0.08.1±0.12 in the IL group. PPP1R12ALZ+ expression was decreased
in the IL group relative to the NP and NIL groups, Fig 5. There was a reducing trend in
PPP1R12ALZ+ expression in NIL compared to the NP group that failed to reach statistical sig-
nificance. PPP1R12BLZ expression was 1.4±0.11-fold relative to control for NP, 0.77±0.08 for
NIL and 0.72±0.17 in the IL group, consistent with a decrease in myometrial PPP1R12BLZ+
mRNA levels during pregnancy and in labor. PPP1R12BLZ+mRNA expression was invariant
between the NIL and IL groups. PPP1R12ALZ- mRNA expression was 0.91±0.06 for NP, 0.94
±0.04 in NIL and 0.21±0.15 in the in-labor group demonstrating a significant decrease in
PPP1R12A mRNA levels in the IL group compared to the NP and NIL groups. PPP1R12ALZ-
expression was invariant between the NP and NIL groups.
In light of the differences in PPP1R12ALZ+ and LZ- expression outlined above, we also
used primers aligned to exons upstream of the LZ region, which are common to both LZ+ and
LZ- isovariants in order to detect the ‘canonical’ PPP1R12A mRNA expression in the three
groups. PPP1R12A mRNA expression was 1.2±0.08-fold relative to control in NP, 0.59±0.04 in
NIL and 0.57±0.11 in the IL group. Our analyses confirm a decrease in PPP1R12A mRNA
expression in myometrium during pregnancy and in labor. Total PPP1R12A levels were similar
in the NIL and IL groups, contrasting the significant reductions in PPP1R12ALZ+ and
PPP1R12ALZ- mRNA expression in IL compared to NIL myometrium.
Table 2. Details of Primers used for quantitative PCR. The primers were based in the human cDNA sequences. The HUGO/GeneBank accession num-
bers, oligonucleotide sequences, position and amplicon size are outlined below and in S1 Table.
Isoform specificity of
primers








SENSE: 50 TTGGAAATGGAAAAAAGGGAACG30 2936 39.1 76.8 120




SENSE: 5’ TGTCGGCAAGAGTCAGTAT 3’ 2957 50 85 104
ANTISENSE: 5’ TGTCGGCAAGAGTCAGTAT 3’ 3060 37.5
• PPP1R12A canonical
• (NM_002480.2)
SENSE: 5’ AAGCACCACATCAACACCAA 3’ 1704 45 60 192
SENSE: 5’ ATGGTCACTGCCGTAGGAAC 3’ 1895 55
• PPP1R12BLZ+
• (NM_002481.3)
SENSE: 5’ GAGATGGAGAAACGGGAGAG 3’ 2797 55 78.9 129




SENSE: 5’ TGTCCGGCAAGAGTCAGTAT 3’ 2813 50 85 108
ANTISENSE: 5’ GTGTCGGATTCAGTTCTGTTAA 3’ 2919 37.5
• PPP1R12B canonical
• (NM_002481.3)
SENSE: 5’ TGAGAAGCCCACAGACACTG 3’ 2025 55 60 227
ANTISENSE: 5’ ATAGCAGGTGGGAACTGGTG 3’ 2251 55
• PPP1R12CLZ+
• (NM_017607.3)
SENSE: 5’ TGGAACTGGAGAGATTCGAGC 3’ 2195 64 86.7 56.8




SENSE: 5’ CGCAGAGGCAAGAACGCT 3’ 2138 64 83.5 87
ANTISENSE: 5’ CGCCCAGTAGATACTGACTCTT 3’ 2239 52
• PPP1R16A
• (NM_032902.5)
SENSE: 5’ TCTTCCCTCCCAGTGTTGTC 3’ 669 55 91.5 200
ANTISENSE: 5’ GTCACAGGCATTGATGTTGG 3’ 862 50
• PPP1R16B
• (NM_015568.2)
SENSE: 5’ CGGACAGGACCAACCTGTAT 3’ 1244 55 86.4 198
ANTISENSE: 5’ CTCGTGGGATCTTGGTAGGA 3’ 1422 55
• MYH1
• (NM_005963)
SENSE: 5’AATCATAAGTGAAGAGTAATTTATCTAAC3’ 5896 24.1 56.4 95
ANTISENSE: 5’ CATAAGTACAAAATGGAGTGACAAAG 3’ 5990 34.6
• ACTA2
• (NM_005963)
SENSE: 5’ TGACGAAGCACAGAGCAAAA 3’ 171 45 56.4 128
ANTISENSE: 5’ GGGCAACACGAAGCTCATT 3’ 298 56.5
doi:10.1371/journal.pone.0164352.t002
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We also observed a decrease in PPP1R12CLZ+mRNA levels in IL relative to NIL.
PPP1R12CLZ expression was 0.30±0.15-fold relative to control in NP, 0.66±0.05 in NIL and
0.15±0.10 in the IL group. PPP1R12CLZ+mRNA expression were invariant between the NP
and NIL groups, Fig 5.
Fig 4. Optimisation of primers directed against PPP1R12A, PPP1R12B, PPP1R12C, PPP1R16A and PPP1R16B isovariants. Panels above show
PCR amplification and dissociation curves obtained for PPP1R12ALZ+, PPP1R12ALZ-, PPP1R12BLZ+, PPP1R12BLZ-, PPP1R12CLZ+, PPP1R12CLZ-,
PPP1R16A and PPP1R16B Curves labelled A-E are representative of specific product formation obtained from human smooth muscle reference cDNA and
human uterine cDNA samples. Similar curves were obtained for other positive controls including human skeletal and cardiac muscle samples. No specific
products were obtained in reactions where the RT enzyme was excluded (RT-) or in water no template control (NTC) reactions. No specific products were
obtained with PPP1R12BLZ- or PPP1R12CLZ- primer sets.
doi:10.1371/journal.pone.0164352.g004
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Fig 5. Human uterine PPP1R12ALZ+, PPP1R12CLZ+ and PPP1R12ALZ- mRNA expression is decreased during in labor. PPP1R12ALZ+,
PPP1R12BLZ+, PPP1R12CLZ+ and PPP1R12ALZ- mRNA expression was determined using quantitative PCR and expressed as mean fold
change relative to an internal calibrator. PCR amplification curves confirmed specific product formation for the four genes above. Quantitative
Myometrial Myosin Phosphatase Isovariant Expression Is Altered during Pregnancy and in Labor
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In summary, our results demonstrate a reduction in PPP1R12ALZ+, PPP1R12CLZ+ and
PPP1R12ALZ- mRNA expression in human myometrium during labor. There was a decrease
in the expression of PPP1R12BLZ+ during pregnancy and in labor.
Expression of PPP1R16A and PPP1R16B mRNA in human
myometrium during pregnancy and labor
PPP1R16A and PPP1R16B mRNA expressions were reduced in the pregnant groups relative to
the non-pregnant group, Fig 6. PPP1R16A mean fold changes were 0.87±0.08 relative to con-
trol in NP, 0.05±0.05 in NIL and 0.25±0.08 for the IL group. PPP1R16B expression was 1.29
±0.09 in NP, 0.51±0.05 in NIL and 0.52±0.08 in IL consistent with a six-fold decrease in expres-
sion during pregnancy and in labor. PPP1R16A and PPP1R16B mRNA expression was invari-
ant in between the pregnant NIL and IL groups.
We also assessed the expression of ribosomal RNA (18S) and two other smooth muscle
related housekeeping genes myosin heavy chain 1 (MYH1) and alpha actin (ACTA2) in the
non-pregnant and pregnant groups in order to determine if the changes above were either due
to a down regulation in mRNA expression or as a consequence of pregnancy and labor induced
exon splicing. MYH1, ACTA2, and 18S mRNA expression were similar in the non-pregnant,
pregnant not in labor and in-labor groups, p>0.05. MYH1 and ACTA2 expression were 1.4
±0.09 and 0.72±0.02-fold relative to control in NP, 1.3±0.07 and 0.64±0.03 in NIL and 1.3
±0.08 and 0.61±0.01 in the IL group, Fig 6. 18S expression was 0.34±0.04 in NP, 0.18±0.06 in
NIL and 0.28±0.06 for the IL group. This indicates that the down-regulation of most of the
MYPT related genes during pregnancy and in labor are not as a consequence of a global down-
regulation in smooth muscle related mRNA but rather due to alternative mechanisms includ-
ing such as exon splicing. The reduction in canonical PPP1R12A levels with pregnancy is in
part due to a reducing trend in PPP1R12ALZ+mRNA expression in the pregnant not in labor
compared to the non-pregnant groups. In contrast, the reduction in total PPP1R12A mRNA
levels with labor is due to changes in both PPP1R12ALZ+ and PPP1R12ALZ- mRNA levels. It
is plausible to conclude that these changes in PPP1R12ALZ+ and PPP1R12ALZ- mRNA levels
with pregnancy and labor onset are isoform specific and may to be due to exon splicing.
In this study we investigated, for the first time in human smoothmuscle, the pattern of
expression of five canonical MYPT isovariants as well as exploring the possible existence of
LZ- isovariants of human MYPT. Moreover, using human uterine smoothmuscle samples
from non-pregnant and pregnant patients, we show that there is a gestational-related change
in expression of severalMYPT isovariants. The possible functional implications of these find-
ings for uterine function in pregnancy are discussed below.
Given the suggestions in the literature that variations in smoothmuscle PPP1R12A LZ
+ and PPP1R12ALZ- isovariants could impart functional consequences [10,16,17], it was sur-
prising that, unlike the chicken and mouse genome, the human genome contains sequence
information for PPP1R12ALZ+ but not PPP1R12ALZ- [7]. By aligning the chicken and mouse
PPP1R12ALZ- sequences with the human PPP1R12ALZ+ sequences we could infer at which
region of human PPP1R12A an insertion of the 31 nucleotide exonic segment, present in
chicken and mouse, would likely arise–should there be a human PPP1R12ALZ- isovariant.
Uniquely, we next inserted a similar putative insert in PPP1R12B and PPP1R12C to switch
from LZ+ to LZ- reads. Subsequent QPCR experimentation indicated the existence of
PCR analyses demonstrate a significant decrease in PPP1R12ALZ+, PPP1R12ALZ- and PPP1R12CLZ+ mRNA expression in in-labor
myometrium (IL) relative to pregnant not in labor (NIL) and non-pregnant (NP) myometrium. PPP1R12BLZ+ mRNA expression was lower in the IL
and NIL groups relative to NP group. PPP1R12CLZ+ levels were similar NP and NIL groups. Bars represent means, *p<0.05, n = 10.
doi:10.1371/journal.pone.0164352.g005
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Fig 6. Human uterine PPP1R16A and PPP1R16B mRNA expression is decreased during pregnancy and in labor. PPP1R16A
and PPP1R16B mRNA expression in non-pregnant (NP), pregnant not in labor (NIL) and in-labor (IL) myometrium were assessed
using quantitative RT-PCR. The amount of individual MYPT mRNA in each sample was determined from human reference smooth
muscle standard curve and quantified as mean fold change relative to an internal calibrator. PPP1R16A and PPP1R16B expression
was significantly less in NIL and IL myometrium than in NP myometrium. PPP1R16A and PPP1R16B mRNA expression was similar in
the NIL and IL groups. The bars represent mean, *p<0.05.
doi:10.1371/journal.pone.0164352.g006
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PPP1R12ALZ- expression in human uterine smoothmuscle but we were unable to detect
PPP1R12BLZ- or PPP1R12CLZ- sequences. This suggests that alternative splicing between LZ
+/ LZ- isovariants of human MYPT in uterine smoothmuscle primarily involves PPP1R12A.
Our predicted PPP1R12ALZ- protein sequence was similar to PPP1R12ALZ- sequences from
other species and another predicted human PPP1R12ALZ- sequence generated by a similar
bioinformatic study[15].
Our results establish the presence of human PPP1R12ALZ- mRNA from a multi-tissue
human smoothmuscle reference homogenate (the commercially-usedhuman reference RNA),
cultured human uterine smoothmuscle cells and human uterine smoothmuscle tissue.We
have previously reported PPP1R12ALZ+ and LZ- mRNA expression in human uterine and
placental blood vessel tissues [14]. The PPP1R12ALZ- nucleotide and amino acid sequences
generated are consistent with recently predicted PPP1R12ALZ- human sequences obtained
from automated computational analysis using an NCBI eukaryotic gene prediction tool [http://
www.ncbi.nlm.nih.gov/nuccore: PPP1R12ALZ- transcript variant X3: XM_011538376.1/ tran-
script variant X8: XM_005268887.2] and other bioinformatic analyses [15]. We are not aware
of any reports of naturally occurringPPP1R12BLZ- and PPP1R12CLZ- isoforms at the time of
this publication, but there are at least five ‘predicted’ PPP1R12B sequences [NP_001161329.1,
NP_001161330.1, XP_011507877.1, XP_011507876.1, XP_011507875.1, XP_011507878.1 and
XP_005245263.1] generated from computational analyses that lack the classic LZ motif.
We show that in late pregnancy there is down-regulation of myometrial PPP1R12A and
PPP1R12BLZ+mRNA relative to the non-pregnant state. PPP1R12ALZ+, PPP1R12CLZ+ and
PPP1R12ALZ-mRNA levels were invariant between the non-pregnant and pregnant not in labor
groups. Labor was associatedwith a reduction in the uterine expression of PPP1R12ALZ+,
PPP1R12CLZ+ and PPP1R12ALZ- mRNA relative to the pregnant not-in-labor group Fig 5,
PPP1R12A-C in S1 File. This is the first such report to show pregnancy-related changes in the dif-
ferential myometrial expression of two otherMYPTLZ+ genes namely pregnancy and in labor.
The reduction in expression of severalMYPTLZ+ isovariants in late pregnancy and/or
labor is consistent with molecular switches favoring an increased contractile phenotype (by vir-
tue of a putative increasedMYLII phosphorylation potential). In addition, a reduction in
PPP1R12ALZ+ and PPP1R12CLZ+ isovariants with labor could confer reduced tissue sensitiv-
ity to PKG-mediated relaxatory influences.Of note, differing levels of PKG-induced Ca2+
desensitization in uterine and placental vasculature have been associated with changes in the
expression of PPP1R12ALZ+ and other contractile associated proteins such as hsp20 and
VASP[14]. However other workers have suggested that only small proportions of NOmediated
relaxation in myometrium are actually mediated via PKG and cGMP related pathways, under-
lining the need for future investigations to explore alternative relaxatory pathways [18].
Other investigators have reported expression of PPP1R12A LZ+ and LZ- isoforms in both
uterine and vascular smooth muscle in a range of animal models. However, findings in respect
of MYPT expression during pregnancy are inconsistent. A 2-3-fold down-regulation of
PPP1R12A mRNA expression in rat myometrium at the end of gestation has been reported by
other investigators [19]. In contrast, Lontay and colleagues reported an increase in total MYPT
mRNA and protein levels in mice and rat uterine smoothmuscle and vascular tissues during
pregnancy [20,21]. A review of other animal and human models has revealed ‘donor age’ as a
potential confounder with remarkably contrasting effects on basal non-smooth and smooth
muscle MYPT expression[21–23]. As there is no clear directional effect of age on MYPT
expression it is therefore difficult to determine what impact, if any, the differences in mean age
between the non-pregnant and pregnant donor groups have on the results above. Interestingly,
the changes in PPP1R12ALZ+, PPP1R12CLZ+ and PPP1R12ALZ- mRNA expression with
labor onset occurs between donor groups with a similar mean age.
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MYPT2 (PPP1R12B) is expressed in the striated muscle and the brain [24]. It has similar
sites of phosphorylation to PPP1R12A and an identical four-leucine heptad repeat in its car-
boxyl terminal region. In addition to its main function in dephosphorylating cardiac MYL, it
has also been suggested to have roles in sarcomere organization during cardiac hypertrophy
[25]. The reduced expression in late pregnancy does not exclude a role of PPP1R12B in regulat-
ing uterine cell hypertrophy in earlier stages of gestation, but such changes as we have observed
are likely to represent a reduced overall phosphatase activity directed to phosphorylatedMYL.
In contrast to PPP1R12ALZ+, PPP1R12BLZ+ levels were similar in both the pregnant not in
labor and in labor samples. The lack of evidence of PPP1R12BLZ- transcripts in our samples
coupled with similarities in the expression patterns of the canonical PPP1R12B and
PPP1R12BLZ+ isovariants in the three groups makes us suggest that previously noted exon
splicing attributed to PPP1R12B by other authors is not present, or at least in a detectable
amount according to our assays, in uterine smooth muscle at present[26]. We may need to use
more primer sets in order to detect PPP1R12BLZ- in our samples.
Our results also demonstrate a 5-6-fold reduction in PPP1R16A and PPP1R16B expression
in human myometrium during pregnancy with no further change in labor, Fig 6, PPP1R16A-B
in S1 File. PPP1R16A and PPP1R16B are prenylatable subunits that inhibit PP1c activity
towards phosphorylatedmyosin. Inhibitory phosphorylation of PPP1R16A by protein kinase
A (PRKA) enhances PP1c activation with a resultant decrease in myosin phosphorylation and
smoothmuscle tone[6].
In light of our findings of a decrease in the expression of several uterineMYPT isovariants
with pregnancy, it is reasonable to speculate that MTPT expression may be regulated by ovarian
hormones estrogen and progesterone. In support of this, estradiol has also been shown to produce
a 2-3-fold increase in aortic smooth PPP1R12A expression in a micemodel of atherosclerosis
[27]. Smoothelin-1 is also known to represses PPP1R12A expression, but pregnancy related
changes onMYPT expression are similar in both wild type and smoothelin-deficientmice[21,28].
Implications for the regulation of uterine function
Our results demonstrate a down regulation in mRNA expression of four MYPT isovariants in
human uterine smoothmuscle during pregnancy suggesting a reduced influence of phospha-
tase activity directed against the regulatory light chains of MYLII. This, in turn, may reflect a
contribution of the regulation of MYPT expression to the shift in molecular physiological char-
acteristics of the uterus from relative quiescence towards activation in preparation for parturi-
tion. That further reductions in PPP1R12A (LZ+ and LZ-) and PPP1R12CLZ+mRNA occur
in in-labor samples supports this notion. If the mRNA data were reflected at protein level, and
MYLP activity, it would be indicative of a shift towards MYL phosphorylation and thereby
increased uterine contractility.
Supporting Information
S1 File. PPP1R12A, PPP1R12B, PPP1R12C, PPP1R16A, PPP1R16B, MYH1, ACTA2 and
18S mRNA expression in non-pregnant and pregnant donors.
(XLSX)
S1 Table. Schematic representation of amplicon positions for PPP1R12A, PPP1R12B,
PPP1R12C and PPP1R16A genes. The nucleotide positions (as indicated by asterisks) of
human PPP1R12A, PPP1R12B and PPP1R12C LZ+ and LZ- primer sequences and the
intended amplicons are displayed, as are those for PPP1R16A, PPP1R16B, MYH1 and ACTA2.
The 31 nucleotide exonic insert, which generates LZ- read, is underlined for individual LZ-
Myometrial Myosin Phosphatase Isovariant Expression Is Altered during Pregnancy and in Labor




We are grateful to the patients who kindly took part in this study and for the assistance of the
midwifery and theatre staff of Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS
Foundation Trust.
Author Contributions
Conceptualization: JL MJT SCR.









Writing – original draft: JL MJT SCR JT.
Writing – review& editing: JL MJT SCR JT.
References
1. Alessi D, MacDougall LK, Sola MM, Ikebe M, Cohen P (1992) The control of protein phosphatase-1 by
targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein
phosphatase-1. Eur J Biochem 210: 1023–1035. PMID: 1336455
2. Kitazawa T, Kobayashi S, Horiuti K, Somlyo AV, Somlyo AP (1989) Receptor-coupled, permeabilized
smooth muscle. Role of the phosphatidylinositol cascade, G-proteins, and modulation of the contractile
response to Ca2+. J Biol Chem 264: 5339–5342. PMID: 2494163
3. Lee MR, Li L, Kitazawa T (1997) Cyclic GMP Causes Ca2+ Desensitization in Vascular Smooth Mus-
cle by Activating the Myosin Light Chain Phosphatase. J Biol Chem 272: 5063–5068. PMID: 9030570
4. Wu X, Somlyo AV, Somlyo AP (1996) Cyclic GMP-dependent stimulation reverses G-protein-coupled
inhibition of smooth muscle myosin light chain phosphate. Biochem Biophys Res Commun 220: 658–
663. PMID: 8607821
5. Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, et al. (1999) Regulation of Myosin Phos-
phatase by a Specific Interaction with cGMP- Dependent Protein Kinase I. Science 286: 1583–1587.
PMID: 10567269
6. Yong J, Tan I, Lim L, Leung T (2006) Phosphorylation of Myosin Phosphatase Targeting Subunit 3
(MYPT3) and Regulation of Protein Phosphatase 1 by Protein Kinase A. J Biol Chem 281: 31202–
31211. doi: 10.1074/jbc.M607287200 PMID: 16920702
7. Chen YH, Chen MX, Alessi DR, Campbell DG, Shanahan C, et al. (1994) Molecular cloning of cDNA
encoding the 110 kDa and 21 kDa regulatory subunits of smooth muscle protein phosphatase 1M.
FEBS Letters 356: 51–55. PMID: 7988720
8. Khatri JJ JK, Brozovich FV, Fisher SA (2001) Role of myosin phosphatase isoforms in cGMP-mediated
smooth muscle relaxation. J Biol Chem 276: 37250–37257. doi: 10.1074/jbc.M105275200 PMID:
11486008
Myometrial Myosin Phosphatase Isovariant Expression Is Altered during Pregnancy and in Labor
PLOS ONE | DOI:10.1371/journal.pone.0164352 October 31, 2016 15 / 16
9. Dirksen WP, Vladic F, Fisher SA (2000) A myosin phosphatase targeting subunit isoform transition
defines a smooth muscle developmental phenotypic switch. Am J Physiol Cell Physiol 278: C589–
600. PMID: 10712248
10. Payne MC, Zhang H-Y, Shirasawa Y, Koga Y, Ikebe M, et al. (2004) Dynamic changes in expression
of myosin phosphatase in a model of portal hypertension. Am J Physiol Heart Circ Physiol 286:
H1801–1810. doi: 10.1152/ajpheart.00696.2003 PMID: 14704233
11. Payne MC, Zhang HY, Prosdocimo T, Joyce KM, Koga Y, et al. (2006) Myosin phosphatase isoform
switching in vascular smooth muscle development. J Mol Cell Cardiol 40: 274–282. doi: 10.1016/j.
yjmcc.2005.07.009 PMID: 16356512
12. Lartey J, Gampel A, Pawade J, Mellor H, Lopez Bernal A (2006) Expression of RND Proteins in human
myometrium. Biol Reprod 75: 452–461. doi: 10.1095/biolreprod.105.049130 PMID: 16554414
13. Hudson CA, Heesom KJ, Lopez Bernal A (2012) Phasic contractions of isolated human myometrium
are associated with Rho-kinase (ROCK)-dependent phosphorylation of myosin phosphatase-targeting
subunit (MYPT1). Mol Hum Reprod 18: 265–279. doi: 10.1093/molehr/gar078 PMID: 22155728
14. Dordea AC SM, Taggart J, Lartey J, Wessel H, Robson SC, et al. (2013) Differential vasodilation of
human placental and myometrial arteries related to myofilament Ca(2+)-desensitization and the
expression of Hsp20 but not MYPT1. Molecular Human Reproduction 19: 727–736. doi: 10.1093/
molehr/gat045 PMID: 23775458
15. Dippold RP, Fisher SA (2014) A bioinformatic and computational study of myosin phosphatase subunit
diversity. Am J Physiol Regul Integr Comp Physiol 307: R256–270. doi: 10.1152/ajpregu.00145.2014
PMID: 24898838
16. Zhang H, Fisher SA (2007) Conditioning Effect of Blood Flow on Resistance Artery Smooth Muscle
Myosin Phosphatase. Circ Res 100: 730–737. doi: 10.1161/01.RES.0000260189.38975.35 PMID:
17293476
17. Fisher SA (2010) Vascular smooth muscle phenotypic diversity and function. Physiol Genomics 42A:
169–187. doi: 10.1152/physiolgenomics.00111.2010 PMID: 20736412
18. Buxton ILO (2004) Regulation of Uterine Function: a Biochemical Conundrum in the Regulation of Smooth
Muscle Relaxation. Mol Pharmacol 65: 1051–1059. doi: 10.1124/mol.65.5.1051 PMID: 15102932
19. Trujillo M, Candenas L, Cintado CG, Magraner J, Fernandez J, et al. (2001) Hormonal regulation of the
contractile response induced by okadaic acid in the rat uterus. J Pharmacol Exp Ther 296: 841–848.
PMID: 11181915
20. Lu Y ZH, Gokina N, Mandala M, Sato O, Ikebe M, et al. (2008) Uterine artery myosin phosphatase iso-
form switching and increased sensitivity to SNP in a rat L-NAME model of hypertension of pregnancy.
American Journal of Physiology Cell Physiology 294: C564–C571. doi: 10.1152/ajpcell.00285.2007
PMID: 18094148
21. Lontay B BK, Weitzel DH, Loiselle D, Fortner C, Lengyel S, et al. (2010) Smoothelin-like 1 protein regu-
lates myosin phosphatase-targeting subunit 1 expression during sexual development and pregnancy.
Journal of Biological Chemistry 285: 29357–29366. doi: 10.1074/jbc.M110.143966 PMID: 20634291
22. Ekman M, Fagher K, Wede M, Stakeberg K, Arner A (2005) Decreased phosphatase activity,
increased Ca2+ sensitivity, and myosin light chain phosphorylation in urinary bladder smooth muscle
of newborn mice. J Gen Physiol 125: 187–196. doi: 10.1085/jgp.200409212 PMID: 15684094
23. Gomez-Pinilla PJ, Gomez MF, Sward K, Hedlund P, Hellstrand P, et al. (2008) Melatonin restores
impaired contractility in aged guinea pig urinary bladder. J Pineal Res 44: 416–425. doi: 10.1111/j.
1600-079X.2007.00544.x PMID: 18194201
24. Fujioka M, Takahashi N, Odai H, Araki S, Ichikawa K, et al. (1998) A new isoform of human myosin
phosphatase targeting/regulatory subunit (MYPT2): cDNA cloning, tissue expression, and chromo-
somal mapping. Genomics 49: 59–68. doi: 10.1006/geno.1998.5222 PMID: 9570949
25. Okamoto R, Kato T, Mizoguchi A, Takahashi N, Nakakuki T, et al. (2006) Characterization and function
of MYPT2, a target subunit of myosin phosphatase in heart. Cellular Signalling 18: 1408–1416. doi:
10.1016/j.cellsig.2005.11.001 PMID: 16431080
26. Arimura T, Suematsu N, Zhou Y-B, Nishimura J, Satoh S, et al. (2001) Identification, Characterization,
and Functional Analysis of Heart-specific Myosin Light Chain Phosphatase Small Subunit. J Biol Chem
276: 6073–6082. doi: 10.1074/jbc.M008566200 PMID: 11067852
27. Cheng JC CH, Tsai IC, Jiang MJ (2013) ROS-mediated downregulation of MYPT1 in smooth muscle
cells: a potential mechanism for the aberrant contractility in atherosclerosis. Lab Invest 93: 422–433.
doi: 10.1038/labinvest.2013.40 PMID: 23419712
28. Borman MA FT, Haystead TA, Macdonald JA (2011) The role of the calponin homology domain of
smoothelin-like 1 (SMTNL1) in myosin phosphatase inhibition and smooth muscle contraction. Mol
Cell Biochem 327: 93–100.
Myometrial Myosin Phosphatase Isovariant Expression Is Altered during Pregnancy and in Labor
PLOS ONE | DOI:10.1371/journal.pone.0164352 October 31, 2016 16 / 16
